Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Pancreatic Neoplasms × MK 2206 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 4 Breast Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Rectal Neoplasms 2 Ovarian Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Salivary Gland Neoplasms 1 Recurrent Squamous Cell Carcinoma of the Nasopharynx 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1

Interventions

Gemcitabine 149 Fluorouracil 45 Capecitabine 45 Oxaliplatin 42 130-nm albumin-bound paclitaxel 42 Albumin-Bound Paclitaxel 38 Leucovorin 31 Erlotinib Hydrochloride 30 pembrolizumab 22 Radiotherapy 22 Irinotecan 21 Radiosurgery 19 Bevacizumab 19 Docetaxel 17 Cyclophosphamide 16 Cetuximab 13 folfirinox 12 Taxes 12 Cisplatin 11 Nivolumab 10 Surgical Procedures, Operative 7 Paclitaxel 7 Ipilimumab 7 dehydroftorafur 6 Standard of Care 6 Radiation 6 spartalizumab 5 ruxolitinib 5 durvalumab 5 avelumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01658943 2016-03-09

S1115

National Cancer Institute (NCI)

Phase 2 Completed

137 enrolled 12 charts

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡